Narrowband UVB light therapy with tacrolimus or calcipotriol for vitiligo
Treatments studied
Part of Skin clinical trials.
This study compares two treatments for vitiligo: narrowband UVB light therapy combined with either tacrolimus ointment or calcipotriol ointment. It aims to see which combination works better and is safer for people with stable, limited vitiligo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have localized vitiligo (patches on limited areas of the body)
- You are between 15 and 70 years old
- Your vitiligo involves no more than 20% of your body surface
- Your vitiligo has been stable (no new or spreading patches) for at least 3 months
- You are not pregnant or breastfeeding
- You do not have skin cancer or other serious skin diseases, and you have not had an allergic reaction to tacrolimus or calcipotriol
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of microneedling, a topical solution called minoxidil, and narrowband UVB light therapy to see if it can improve stable vitiligo patches. It may help repigment the skin where color has been lost.
This study tests a gel containing latanoprost on vitiligo patches in teens. It aims to see if the gel can help restore skin color in stable, non-segmental vitiligo.
This trial compares two medicines—oral tacrolimus and dexamethasone micro-pulse therapy—in children aged 4 to 12 whose vitiligo is spreading quickly. The goal is to see which treatment works better to stop the spread and help color return to the skin.
This study compares two treatments for widespread vitiligo: one is a combination of light therapy and a medication called Psoralen (PUVA), and the other is a pill called Tofacitinib (a JAK inhibitor) that may help restore skin color. The goal is to see which treatment works better and is safer for adults with stable vitiligo affecting a large area of the body.
This study tests whether combining hyperbaric oxygen (breathing pure oxygen in a special chamber) with narrowband UVB light therapy can improve vitiligo, a condition that causes white patches on the skin. The treatment aims to restore skin color by helping skin cells produce pigment.
This study compares two treatments for mild to moderate psoriasis: Botox injections and a tacrolimus ointment (a topical medicine that calms the immune system). If you qualify, you may get one of these treatments to see which is more effective and safe for your skin.
Hear when a new Vitiligo - Macular Depigmentation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.